Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma

International Journal of Immunotherapy

Volumn 14, Issue 3, 1998, Pages 163-168

  Demir, G ^a   Demirelli, F ^a   Ozguroglu, M ^a   Molinas Mandel, N ^a   Buyukunal, E ^a   Tuzuner, N ^a   Serdengecti, S ^a   Berkarda, B ^a  

^a Zino Apt 11 6 ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN; HLA DR ANTIGEN; IMMUNOSTIMULATING AGENT; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MALE; MELANOMA; MEMORY CELL; METASTASIS; NATURAL KILLER CELL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0032427797     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)